AZN
AstraZeneca PLC
stock NASDAQ ADR

Lots of pharma companies have better pipelines at 13x-17x earnings but i NEVER heard any of them mentioned here. Why? Because they're in uptrends. Try $REGN $AZN $ABBV for three good options with much more clear 2026 and 2027 growth. Which is what the market wants now. Zero posts about them here naturally outside REGN

Lots of pharma companies have better pipelines at 13x-17x earnings but i NEVER heard any of them mentioned here. Why? Because they're in uptrends. Try $REGN $AZN $ABBV for three good options with much more clear 2026 and 2027 growth. Which is what the market wants now. Zero posts about them here naturally outside REGN

The third quarter earnings season is in full swing, with several AI players reporting results this week, including [Palantir](https://finance.yahoo.com/news/palantir-q4-outlook-beats-wall-street-estimates-despite-us-government-shutdown-worries-182343901.html) ([PLTR](https://finance.yahoo.com/quote/PLTR)), [AMD](https://finance.yahoo.com/news/amd-beats-q3-estimates-on-top-and-bottom-line-offers-strong-q4-guidance-202400302.html) ([AMD](https://finance.yahoo.com/quote/AMD)), and [Supermicro](https://finance.yahoo.com/news/supermicro-stock-plummets-as-q1-earnings-revenue-falls-short-of-wall-street-estimates-211659954.html) ([SMCI](https://finance.yahoo.com/quote/SMCI)).
So far, the earnings season is off to a positive start. As of Oct. 31, 64% of S&P 500 companies have reported results, according to[ FactSet data](https://advantage.factset.com/hubfs/Website/Resources%20Section/Research%20Desk/Earnings%20Insight/EarningsInsight_103125.pdf), and analysts are expecting a 10.7% jump in earnings per share during the third quarter. If that figure holds, it would mark the fourth straight quarter of double-digit earnings growth but a deceleration from the 12% earnings growth reported in Q2 of this year.
Expectations were slightly lower coming into the quarter, as analysts expected S&P 500 companies to report a 7.9% jump in earnings per share during the third quarter.
This week, AI beneficiaries such as Palantir, AMD, Supermicro, Constellation Energy ([CEG](https://finance.yahoo.com/quote/CEG)), Qualcomm ([QCOM](https://finance.yahoo.com/quote/QCOM)), and Arm Holdings ([ARM](https://finance.yahoo.com/quote/ARM)) will provide quarterly updates.
Other notable results will come from [Uber](https://finance.yahoo.com/news/uber-stock-dips-despite-strong-q3-earnings-with-wall-street-wanting-more-121915603.html) ([UBER](https://finance.yahoo.com/quote/UBER)), Pfizer ([PFE](https://finance.yahoo.com/quote/PFE)), [Spotify](https://finance.yahoo.com/news/spotify-tops-q3-earnings-estimates-as-margins-rebound-and-price-hike-speculation-builds-112245986.html)([SPOT](https://finance.yahoo.com/quote/SPOT)), Marriott ([MAR](https://finance.yahoo.com/quote/MAR)), Novo Nordisk ([NVO](https://finance.yahoo.com/quote/NVO)), McDonald's ([MCD](https://finance.yahoo.com/quote/MCD)), AppLovin ([APP](https://finance.yahoo.com/quote/APP)), Robinhood ([HOOD](https://finance.yahoo.com/quote/HOOD)), DoorDash ([DASH](https://finance.yahoo.com/quote/DASH)), Snap ([SNAP](https://finance.yahoo.com/quote/SNAP)), AstraZeneca ([AZN](https://finance.yahoo.com/quote/AZN)), Airbnb ([ABNB](https://finance.yahoo.com/quote/ABNB)), and Warner Bros. Discovery ([WBD](https://finance.yahoo.com/quote/WBD)).